Page last updated: 2024-08-26

firefly luciferin and Cancer of Prostate

firefly luciferin has been researched along with Cancer of Prostate in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, C; Karelia, D; Kim, S; Lu, J; Qin, C; Sharma, A; Tang, S; Zhang, Y1
Blanco, J; El Hilali, N; Rubio, N1
Contag, CH; Goun, EA; Jones, LR; Rothbard, JB; Shinde, R; Wender, PA1
Bhang, HE; Bressler, JP; Lal, B; Laterra, J; Neal, J; Pomper, MG; Zhang, Y1
Brunetti, A; Claudio, L; Claudio, PP; Denvir, J; Gossman, MS; Greco, A; Howard, CM; Lopez, JP; Nande, R; Salvatore, M1
Butterworth, KT; Cole, AJ; Hounsell, AR; Jain, S; McCarthy, HO; McMahon, SJ; O'Sullivan, JM; Prise, KM; Redmond, KM1

Other Studies

6 other study(ies) available for firefly luciferin and Cancer of Prostate

ArticleYear
Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.
    The Prostate, 2019, Volume: 79, Issue:9

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Firefly Luciferin; Heterografts; Humans; Immunohistochemistry; Luminescent Measurements; Male; Mice; Mice, SCID; Neoplasm Transplantation; Predictive Value of Tests; Prostatic Neoplasms; Tumor Burden

2019
Noninvasive in vivo whole body luminescent analysis of luciferase labelled orthotopic prostate tumours.
    European journal of cancer (Oxford, England : 1990), 2004, Volume: 40, Issue:18

    Topics: Animals; Antineoplastic Agents, Phytogenic; Firefly Luciferin; Luciferases; Luminescent Agents; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Prostatic Neoplasms; Tumor Cells, Cultured

2004
Releasable luciferin-transporter conjugates: tools for the real-time analysis of cellular uptake and release.
    Journal of the American Chemical Society, 2006, May-24, Volume: 128, Issue:20

    Topics: 2,2'-Dipyridyl; Animals; Biological Transport; Cell Line, Tumor; Cells; Disulfides; Firefly Luciferin; Luciferases; Luminescent Measurements; Male; Prostatic Neoplasms; Transfection

2006
ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging.
    Cancer research, 2007, Oct-01, Volume: 67, Issue:19

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Dogs; Female; Firefly Luciferin; Humans; Luciferases, Firefly; Luminescent Agents; Luminescent Measurements; Male; Mice; Mice, Nude; Multidrug Resistance-Associated Protein 2; Neoplasm Proteins; Prostatic Neoplasms; Substrate Specificity

2007
Microbubble-assisted p53, RB, and p130 gene transfer in combination with radiation therapy in prostate cancer.
    Current gene therapy, 2013, Jun-01, Volume: 13, Issue:3

    Topics: Adenoviridae; Animals; Apoptosis; Benzothiazoles; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Female; Gene Transfer Techniques; Genes, p53; Genetic Therapy; Genetic Vectors; Humans; Luminescent Measurements; Male; Mice; Mice, Inbred BALB C; Microbubbles; Prostatic Neoplasms; Retinoblastoma Protein; Retinoblastoma-Like Protein p130; Transgenes; Ultrasonography; X-Rays; Xenograft Model Antitumor Assays

2013
Conventional in vivo irradiation procedures are insufficient to accurately determine tumor responses to non-uniform radiation fields.
    International journal of radiation biology, 2015, Volume: 91, Issue:3

    Topics: Animals; Benzothiazoles; Cell Line, Tumor; Diagnostic Imaging; Humans; Luminescent Measurements; Male; Mice; Mice, SCID; Neoplasms, Experimental; Prostatic Neoplasms; Radiobiology; Radiotherapy, Image-Guided; Translational Research, Biomedical; Xenograft Model Antitumor Assays

2015